MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,534,800 | -41.2% | 8,153,480 | -26.9% | 0.03% | -37.0% |
| Q2 2023 | $138,647,403 | -15.8% | 11,154,256 | -5.1% | 0.05% | -17.9% |
| Q1 2023 | $164,722,392 | -11.8% | 11,757,487 | -9.9% | 0.06% | -13.8% |
| Q4 2022 | $186,716,307 | -48.3% | 13,047,960 | -7.8% | 0.06% | -51.9% |
| Q3 2022 | $361,273,000 | +0.2% | 14,150,891 | +11.5% | 0.14% | +8.9% |
| Q2 2022 | $360,556,000 | +14.0% | 12,691,171 | +41.6% | 0.12% | +31.9% |
| Q1 2022 | $316,198,000 | -5.7% | 8,965,103 | +12.0% | 0.09% | +2.2% |
| Q4 2021 | $335,326,000 | +23.3% | 8,003,021 | +44.4% | 0.09% | +15.0% |
| Q3 2021 | $272,067,000 | +29.9% | 5,543,329 | +10.4% | 0.08% | +31.1% |
| Q2 2021 | $209,460,000 | +9.2% | 5,019,413 | -6.8% | 0.06% | +3.4% |
| Q1 2021 | $191,855,000 | +61.4% | 5,383,118 | +27.1% | 0.06% | +55.3% |
| Q4 2020 | $118,837,000 | – | 4,236,607 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |